Emily N. Devericks

University of North Carolina at Chapel Hill

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “ERα is an RNA-binding protein sustaining tumor cell survival and drug resistance”.

ERα is an RNA-binding protein sustaining tumor cell survival and drug resistance

Cell(2021)10.1016/j.cell.2021.08.036

N/A

0.776DataRank · unranked

175 citations

Peiwei Huangyang, Ying Wang, Lingru Xue, Emily N. Devericks, Hao G. Nguyen +7 more

Revealing molecular pathways for cancer cell fitness through a genetic screen of the cancer translatome

Cell Reports(2021)10.1016/j.celrep.2021.109321

N/A

0DataRank · unranked

14 citations

Zhiqiang Hu, Martina Rama, Emily N. Devericks, Jacob Weiss, Gary G. Chiang +6 more

Hypoxia-mediated suppression of pyruvate carboxylase drives tumor microenvironment immunosuppression

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.04.06.487050

N/A

0DataRank · unranked

0 citations

Eylem Kulkoyluoglu‐Cotul, Alexander J. Pfeil, Emily N. Devericks, Hao Chen, Violet A. Kiesel +5 more

Hypoxia-mediated repression of pyruvate carboxylase drives immunosuppression

Breast Cancer Research(2024)10.1186/s13058-024-01854-1

N/A

0DataRank · unranked

10 citations

Eylem Kulkoyluoglu‐Cotul, Alexander J. Pfeil, Emily N. Devericks, Muhammad Hassan Safdar, Marvis Monteiro +13 more

Hypoxia-mediated repression of pyruvate carboxylase drives immunosuppression

UNC Libraries(2024)10.17615/4qg9-b774

N/A

0DataRank · unranked

0 citations

Dorothy Teegarden, Violet A. Kiesel, Stephen D. Hursting, Hao Chen, Eylem Kulkoyluoglu‐Cotul +13 more

The nonsteroidal anti-inflammatory drug sulindac reverses obesity-driven immunosuppression and triple-negative breast cancer progression

Breast Cancer Research(2025)10.1186/s13058-025-02134-2

N/A

0DataRank · unranked

0 citations

Shannon B. McDonell, Lydia K. Eisenbeis, Emily N. Devericks, Jobin Chandi, Om Dave +16 more